Menu Search
Equities

Solventum Corp

SOLV:NYQ

Solventum Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)72.34
  • Today's Change0.21 / 0.29%
  • Shares traded886.23k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Solventum Corp had no change in net income (1.35bn). Revenues were little changed (from 8.13bn to 8.20bn.) Year on year Solventum Corp had little change in net income (from 1.34bn to 1.35bn). Revenues were also little changed (from 8.13bn to 8.20bn.)
Gross margin56.98%
Net profit margin12.89%
Operating margin18.70%
Return on assets7.50%
Return on equity14.50%
Return on investment8.72%
More ▼

Cash flow in USDView more

In 2023, Solventum Corp increased its cash reserves by 218.03%, or 133.00m. The company earned 1.92bn from its operations for a Cash Flow Margin of 23.36%. In addition the company used 230.00m on investing activities and also paid 1.55bn in financing cash flows.
Cash flow per share9.34
Price/Cash flow per share7.72
Book value per share16.60
Tangible book value per share-36.50
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items marginally increased 0.22%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-15.83
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.